Back to News
Market Impact: 0.25

Analysts Forecast 10% Upside For ITOT

ITOTMLYSMEGOSWNDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & PositioningCorporate Guidance & Outlook
Analysts Forecast 10% Upside For ITOT

The iShares Core S&P Total U.S. Stock Market ETF (ITOT) has an implied analyst target price of $159.09, indicating a 9.52% upside from its current $145.26, derived from the weighted average of its underlying holdings' analyst targets. This projection suggests potential appreciation within the broad U.S. market, with specific holdings like Mineralys Therapeutics (MLYS), Montrose Environmental Group (MEG), and OneSpaWorld Holdings (OSW) showing even higher individual upsides ranging from 13.98% to 16.20%. However, the analysis also prompts investors to critically assess the recency and justification of these analyst targets.

Analysis

Based on a weighted average of its underlying holdings' analyst targets, the iShares Core S&P Total U.S. Stock Market ETF (ITOT) possesses an implied 12-month target price of $159.09, representing a 9.52% potential upside from its recent price of $145.26. This aggregate calculation suggests a constructive outlook on the broad U.S. equity market as perceived by sell-side analysts. The analysis highlights specific components with even greater perceived upside, including Mineralys Therapeutics (MLYS), Montrose Environmental Group (MEG), and OneSpaWorld Holdings (OSW), which have consensus targets indicating potential gains of 16.20%, 14.30%, and 13.98%, respectively. However, the report is presented with a significant caveat, questioning whether these price targets are overly optimistic or potentially outdated. This raises the critical question for investors of whether the underlying fundamentals justify such optimism or if these targets are susceptible to future downgrades should company or industry developments not meet expectations.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo